🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
608,49 USD
Máx. histórico
608,49
0 días
Split 2:1 del 23/09/2009
Caída desde máximo
En máximo
Rango 52 semanas
432,53 – 614,23
Variación hoy
+1,19%
Cierre anterior
601,32
Rango de hoy
578,28 – 614,23
Volumen hoy
908.530
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,95%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,57 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 22 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 10/06/2014 | 96,50 | 97,56 | 94,80 | 96,35 | -0,43% | 2,86% | 493.900 |
| 09/06/2014 | 96,27 | 97,67 | 95,58 | 96,77 | +0,47% | 2,17% | 356.600 |
| 06/06/2014 | 97,01 | 98,00 | 95,59 | 96,32 | -0,68% | 2,48% | 398.500 |
| 05/06/2014 | 96,99 | 97,56 | 95,43 | 96,98 | +0,29% | 2,20% | 343.000 |
| 04/06/2014 | 95,21 | 96,93 | 94,98 | 96,70 | +1,13% | 2,05% | 417.700 |
| 03/06/2014 | 95,25 | 95,69 | 94,57 | 95,62 | +0,04% | 1,18% | 540.700 |
| 02/06/2014 | 96,21 | 96,73 | 94,73 | 95,58 | -0,17% | 2,08% | 573.700 |
| 30/05/2014 | 95,84 | 96,22 | 95,18 | 95,74 | +0,00% | 1,09% | 697.500 |
| 29/05/2014 | 94,86 | 96,51 | 94,65 | 95,74 | +0,94% | 1,96% | 895.900 |
| 28/05/2014 | 98,20 | 99,10 | 94,78 | 94,85 | -3,71% | 4,40% | 873.800 |
| 27/05/2014 | 100,00 | 100,38 | 98,11 | 98,50 | -0,89% | 2,27% | 586.700 |
| 23/05/2014 | 100,60 | 101,50 | 98,87 | 99,38 | -1,56% | 2,61% | 388.600 |
| 22/05/2014 | 99,42 | 102,38 | 99,10 | 100,95 | +1,78% | 3,30% | 592.600 |
| 21/05/2014 | 99,15 | 99,59 | 97,94 | 99,18 | +0,58% | 1,66% | 392.600 |
| 20/05/2014 | 101,56 | 102,31 | 98,07 | 98,61 | -2,98% | 4,17% | 596.900 |
| 19/05/2014 | 100,41 | 101,80 | 100,02 | 101,64 | +0,99% | 1,77% | 688.500 |
| 16/05/2014 | 101,46 | 101,66 | 99,77 | 100,64 | -0,84% | 1,86% | 482.000 |
| 15/05/2014 | 102,97 | 103,41 | 100,26 | 101,49 | -1,56% | 3,06% | 503.600 |
| 14/05/2014 | 103,78 | 104,60 | 101,59 | 103,10 | -0,85% | 2,90% | 511.100 |
| 13/05/2014 | 107,66 | 107,93 | 103,72 | 103,98 | -2,28% | 3,91% | 986.400 |
| 12/05/2014 | 106,67 | 107,81 | 105,93 | 106,41 | -0,08% | 1,76% | 706.700 |
| 09/05/2014 | 105,48 | 107,13 | 104,39 | 106,50 | +1,08% | 2,60% | 637.500 |
| 08/05/2014 | 107,10 | 109,24 | 104,50 | 105,36 | -2,27% | 4,43% | 975.100 |
| 07/05/2014 | 107,14 | 107,98 | 105,42 | 107,81 | +0,80% | 2,39% | 939.600 |
| 06/05/2014 | 106,00 | 107,98 | 104,88 | 106,95 | +0,37% | 2,92% | 1.198.900 |
| 05/05/2014 | 103,30 | 106,70 | 102,14 | 106,56 | +2,25% | 4,41% | 994.900 |
| 02/05/2014 | 102,00 | 104,83 | 100,55 | 104,22 | +1,98% | 4,20% | 1.077.400 |
| 01/05/2014 | 100,58 | 103,61 | 98,42 | 102,20 | +2,19% | 5,16% | 1.339.100 |
| 30/04/2014 | 94,89 | 100,60 | 91,26 | 100,01 | +5,88% | 9,84% | 1.510.100 |
| 29/04/2014 | 91,68 | 96,24 | 89,58 | 94,46 | +6,13% | 7,26% | 1.535.500 |